Literature DB >> 17493745

Constitutive and inducible nuclear factor-kappaB in immortalized normal human bronchial epithelial and non-small cell lung cancer cell lines.

Johnson Baby1, Brian F Pickering, Y N Vashisht Gopal, Michael W Van Dyke.   

Abstract

Constitutive activation of the proinflammatory nuclear factor kappaB (NF-kappaB) transcription factor p65(RelA)/p50 has been implicated in many cancers, including leukemias, lymphomas, and several solid tumors, including lung cancer. In many cases, constitutive NF-kappaB activation can be recapitulated in cell lines isolated from these cancers. To test whether this is the case with non-small cell lung cancer (NSCLC) cell lines, we investigated the basal levels of NF-kappaB proteins, their subcellular distribution, their DNA-binding activities, and the expression of NF-kappaB-responsive genes in 10 NSCLC cell lines. The immortalized human bronchial epithelial cell line BEAS-2B served as a normal control. We found little evidence of substantial constitutive NF-kappaB activation in NSCLC cell lines, although most all of the normal and NSCLC cells possessed inducible NF-kappaB. Our findings provide a resource for the use of particular NSCLC cell lines for the investigation of constitutive and inducible NF-kappaB activity in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17493745     DOI: 10.1016/j.canlet.2007.03.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

Review 1.  Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades.

Authors:  Z Yang; L Song; C Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-12       Impact factor: 3.428

Review 2.  NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer.

Authors:  Yihui Fan; Renfang Mao; Jianhua Yang
Journal:  Protein Cell       Date:  2013-03-13       Impact factor: 14.870

3.  5-aminolaevulinic acid/photo-dynamic therapy and gefitinib in non-small cell lung cancer cell lines: a potential strategy to improve gefitinib therapeutic efficacy.

Authors:  I Postiglione; A Chiaviello; S M Aloj; G Palumbo
Journal:  Cell Prolif       Date:  2013-08       Impact factor: 6.831

4.  Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3.

Authors:  Alpna Tyagi; Rana P Singh; Kumaraguruparan Ramasamy; Komal Raina; Elizabeth F Redente; Lori D Dwyer-Nield; Richard A Radcliffe; Alvin M Malkinson; Rajesh Agarwal
Journal:  Cancer Prev Res (Phila)       Date:  2009-01

Review 5.  NF-kappaB and cancer: how intimate is this relationship.

Authors:  Sahdeo Prasad; Jayaraj Ravindran; Bharat B Aggarwal
Journal:  Mol Cell Biochem       Date:  2009-10-08       Impact factor: 3.396

6.  Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway.

Authors:  Xianbin Li; Liangzhong Shen; Xuequn Shang; Wenbin Liu
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

7.  PAX2 Expression in Ovarian Cancer.

Authors:  Huijuan Song; Suet-Yan Kwan; Daisy I Izaguirre; Zhifei Zu; Yvonne T Tsang; Celestine S Tung; Erin R King; Samuel C Mok; David M Gershenson; Kwong-Kwok Wong
Journal:  Int J Mol Sci       Date:  2013-03-15       Impact factor: 5.923

8.  Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo.

Authors:  Ilona Rousalova; Sulagna Banerjee; Veena Sangwan; Kristen Evenson; Joel A McCauley; Robert Kratzke; Selwyn M Vickers; Ashok Saluja; Jonathan D'Cunha
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

9.  Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.

Authors:  L-H Wang; Y Li; S-N Yang; F-Y Wang; Y Hou; W Cui; K Chen; Q Cao; S Wang; T-Y Zhang; Z-Z Wang; W Xiao; J-Y Yang; C-F Wu
Journal:  Br J Cancer       Date:  2013-12-03       Impact factor: 7.640

Review 10.  NF-κB Expression and Outcomes in Solid Tumors: A Systematic Review and Meta-Analysis.

Authors:  Dang Wu; Pin Wu; Lufeng Zhao; Lijian Huang; Zhigang Zhang; Shuai Zhao; Jian Huang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.